CRL Stock Quote Price and Forecast | CNN

CRL

Charles River Laboratories International, Inc.

Key terms

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Apr 04 8:01am ET Charles River to perform plasmid production for Ship of Theseus by TipRanks Mar 21 8:06am ET Charles River extends gene therapy manufacturing alliance with NUS Medicine by TipRanks Mar 18 9:06am ET Charles River price target raised to $290 from $200 at Argus by TipRanks Mar 04 7:14am ET Durect, Charles River enter collaboration agreement for ALZET product line by TipRanks Feb 29 5:37am ET Charles River enters pact with Wheeler Bio for Portable CMC platform by TipRanks Feb 20 8:35am ET Charles River announces stem cells collaboration with Pluristyx by TipRanks Feb 16 8:34am ET Charles River price target raised to $235 from $205 at Morgan Stanley by TipRanks Feb 16 7:20am ET Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Charles River Labs (CRL) and Shockwave Medical (SWAV) by TipRanks Feb 15 7:25pm ET Evercore ISI Remains a Buy on Charles River Labs (CRL) by TipRanks Feb 15 8:21am ET Charles River downgraded to Neutral at Guggenheim on valuation by TipRanks Feb 15 7:58am ET Charles River price target raised to $260 from $193 at TD Cowen by TipRanks Feb 15 7:54am ET Charles River price target raised to $290 from $270 at UBS by TipRanks Feb 15 6:24am ET Charles River price target raised to $268 from $252 at Baird by TipRanks Feb 15 6:18am ET Charles River Labs: A Cautious Hold Amidst Anticipated Second-Half Recovery by TipRanks Feb 15 6:15am ET Charles River downgraded to Neutral from Buy at Guggenheim by TipRanks Feb 15 6:06am ET Buy Rating Affirmed for Charles River Labs Amid Strong Financials and Positive Future Outlook by TipRanks Feb 14 9:55am ET Early notable gainers among liquid option names on February 14th by TipRanks Feb 14 7:15am ET Charles River sees FY24 EPS $10.90-$11.40, consensus $11.37 by TipRanks Feb 14 7:11am ET Charles River reports Q4 EPS $2.46, consensus $2.40 by TipRanks Jan 10 6:50am ET Charles River price target raised to $252 from $220 at Baird by TipRanks Jan 10 5:35am ET Maintaining Buy on Charles River Labs: Unwarranted Downturn Presents Attractive Entry Point by TipRanks

Apr 15 8:30am ET STOCK INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Charles River Laboratories Intl. (CRL) and Encourages Long-Term Investors to Contact the Firm by Newsfile Apr 15 8:09am ET SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Charles River Laboratories International, Inc. (CRL) by Newsfile Apr 02 8:30am ET SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Charles River Laboratories Intl. (CRL) and Encourages Long-Term Investors to Contact the Firm for Additional Information by Newsfile Apr 02 8:04am ET SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Charles River Laboratories International, Inc. (CRL) by Newsfile

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.

Frank Franklin II/AP

Trump Media stock ends session 15% higher after two very bad days

Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.

Patrick Reddy/The Enquirer/AP/File

Private equity finds its next bet: college admissions

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.

Scott Olson/Getty Images

Trump’s stock tumbles again after Truth Social announces it’s getting into streaming

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images

Samuel Corum/Bloomberg/Getty Images

Geopolitical strife is roiling Wall Street. Here’s what investors are watching